about
Systems medicine: the future of medical genomics and healthcareDual-color proteomic profiling of complex samples with a microarray of 810 cancer-related antibodiesHypoxic tumor cell modulates its microenvironment to enhance angiogenic and metastatic potential by secretion of proteins and exosomesCombined blood/tissue analysis for cancer biomarker discovery: application to renal cell carcinomaMathematical model identifies blood biomarker-based early cancer detection strategies and limitationsA strategy for blood biomarker amplification and localization using ultrasound.Beyond CA125: the coming of age of ovarian cancer biomarkersProteomics Research in SchizophreniaGlycosylation-Based Serum Biomarkers for Cancer Diagnostics and PrognosticsGraft-versus-host disease biomarkers: omics and personalized medicinePorous bead-based diagnostic platforms: bridging the gaps in healthcareHaloTag technology: a versatile platform for biomedical applicationsProtein-targeted corona phase molecular recognitionCurrent application of proteomics in biomarker discovery for inflammatory bowel diseaseTop-down quantitative proteomics identified phosphorylation of cardiac troponin I as a candidate biomarker for chronic heart failureColorectal Cancer Classification and Cell Heterogeneity: A Systems Oncology ApproachProteinSeq: high-performance proteomic analyses by proximity ligation and next generation sequencingBiosensors: the new wave in cancer diagnosis.Comparing human pancreatic cell secretomes by in vitro aptamer selection identifies cyclophilin B as a candidate pancreatic cancer biomarker.Integrated proteomic analysis of human cancer cells and plasma from tumor bearing mice for ovarian cancer biomarker discovery.A mouse to human search for plasma proteome changes associated with pancreatic tumor development.Proteomic analysis of ovarian cancer cells reveals dynamic processes of protein secretion and shedding of extra-cellular domains.Mesoporous silica chips for selective enrichment and stabilization of low molecular weight proteome.A decade of proteomics studies of glaucomatous neurodegeneration.Comparative proteomic analysis of plasma membrane proteins between human osteosarcoma and normal osteoblastic cell linesProtein modifications as potential biomarkers in breast cancer.Identification of cell membrane protein stress-induced phosphoprotein 1 as a potential ovarian cancer biomarker using aptamers selected by cell systematic evolution of ligands by exponential enrichment.Postmenopausal estrogen and progestin effects on the serum proteome.Are plasma IL-10 levels a useful marker of human clinical tolerance in peanut allergy?Statistical analysis of variation in the human plasma proteome.Tailoring of the nanotexture of mesoporous silica films and their functionalized derivatives for selectively harvesting low molecular weight proteinLabel-free biomarker sensing in undiluted serum with suspended microchannel resonatorsElevated FOXO6 expression correlates with progression and prognosis in gastric cancer.Multiplex Immunosensor Arrays for Electrochemical Detection of Cancer Biomarker Proteins.Programmable nano-bio-chip sensors: analytical meets clinical.The knowledge-integrated network biomarkers discovery for major adverse cardiac eventsUltrasensitive electrochemical immunosensor for oral cancer biomarker IL-6 using carbon nanotube forest electrodes and multilabel amplification.Concordant release of glycolysis proteins into the plasma preceding a diagnosis of ER+ breast cancer.Fast proteomic protocol for biomarker fingerprinting in cancerous cells.Blood-based biomarkers of Alzheimer's disease: challenging but feasible
P2860
Q24288895-2B862A23-F137-47F0-B55F-9D5CF7D37313Q24604179-5D8C9E32-3431-481A-BF0C-B0741645E371Q24604279-EA7C1472-C199-4147-8734-37B12592862CQ24614307-DD267C2E-2166-4605-AD15-5D055D69C8D8Q24614865-577363DE-9C4D-4B24-BECD-7D4A3927F6A4Q24648447-F7EA0ACB-A39E-4DAB-BA77-5DEDC1709C79Q24651567-CB9D987A-ECDE-4FB6-ADAF-68D8B57FE308Q26766821-2AD20075-6370-41AB-9CA7-90B9977A033AQ26778227-6701B5CC-114D-404B-AB14-4D04E9E157DFQ26824540-32397DF4-D075-408C-A972-742D09416973Q26829421-38C3C8C6-4023-43A6-B83F-C58D04CB752FQ26997400-8D004D44-6E32-4370-8D22-B188A1EDF238Q27336235-12987C4B-BA35-4067-99BA-652404786EE8Q28078755-072256AE-936C-41A4-AACE-C58029CB5AECQ28243166-F2C84CCA-BD40-4300-A167-E58FCE4D34D6Q28647615-8C00CCEC-B917-4BB1-A2D1-93A414F35047Q28744412-D145C481-40A2-4479-A755-6FF50CFA6C6AQ30447534-EBB203F2-0622-4D95-9737-4AD37C881B28Q30513800-CAAD9B31-6719-40E4-9092-18B2001E2427Q30914170-06551B48-04D7-4351-AC48-ACE45E869D07Q33343004-1B60C0B9-ADB6-4B62-89D4-2940CD9DAF48Q33344488-E8D4C1FA-12A1-4372-8012-3CD5BED317E0Q33518743-1728730B-60DD-451E-81B2-E8A7D09E8640Q33570764-1B31C649-7465-48BB-A957-C371E40C4803Q33578377-EB0B42DB-848A-400E-B966-B40291CE4941Q33586407-740D35C9-5135-4C20-A705-22CBD1F1B2EAQ33598785-BB94CA73-7E22-4879-86B5-2DAD5026D079Q33600109-E1ED380B-33E5-4A3E-8C08-CB5DAFB5976CQ33612250-AD840C18-F006-4BCE-8D44-0070D4522445Q33622162-E7F0595F-9833-4B21-969A-40D1DB974720Q33622478-C19AB7BF-A865-4FFD-B56B-57DE2E0CD95AQ33761414-73B96A57-1E47-480B-8DE7-43AA61886765Q33761863-7DAE3499-DF17-4D25-8B1A-DC98291A49D2Q33764870-9044FA5E-C84F-40C9-B464-1C68C26794CCQ33785871-5CD33D7F-4D95-4769-9C8C-BCE1587345E5Q33789038-C285AA68-8338-4A6E-A08B-BF51DBFE874AQ33790362-0FBFAEC4-B97C-463B-8E83-4EC9FDB418C5Q33790538-7CAFB22A-0A1C-4262-97B1-7F3F9380B6F9Q33798196-F17B7795-DBBC-4866-BD82-39E65397AA41Q33824444-6C907293-95DB-452D-BAF9-D9C38095F62B
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Mining the plasma proteome for cancer biomarkers.
@en
Mining the plasma proteome for cancer biomarkers.
@nl
type
label
Mining the plasma proteome for cancer biomarkers.
@en
Mining the plasma proteome for cancer biomarkers.
@nl
prefLabel
Mining the plasma proteome for cancer biomarkers.
@en
Mining the plasma proteome for cancer biomarkers.
@nl
P356
P1433
P1476
Mining the plasma proteome for cancer biomarkers.
@en
P2093
Samir M Hanash
Vitor M Faca
P2860
P2888
P304
P356
10.1038/NATURE06916
P407
P577
2008-04-01T00:00:00Z
P6179
1015356616